Researchers are preparing a large multicenter trial in France to study a specific treatment for ischemic stroke. The study focuses on patients who have experienced a major blockage in the arteries supplying blood to the brain within 24 hours of their symptoms starting.
The trial will compare two different approaches. One group will receive intra-arterial thrombolysis, where the medication alteplase is injected directly into the affected artery. The other group will not receive this specific intra-arterial treatment. The goal is to see if this direct delivery improves physical function and survival rates.
Because this is a protocol study, no results have been collected or shared yet. The trial is designed to provide high-quality data on whether this method is safe and effective for patients in Europe. Since the study is still in the planning phase, these findings cannot be used to change current medical treatments at this time.
